Ignacio Moriyón

Prof. Ignacio Moriyón

orcid

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Preventive Veterinary Medicine
Verified
Journal Article
Closed access
JGJacques Godfroid
Jacques Godfroid
HSH.C. Scholz
H.C. Scholz
TBT. Barbier
T. Barbier
CNC. Nicolas
C. Nicolas
PWP. Wattiau
P. Wattiau
JLJean-Jacques Letesson
Jean-Jacques Letesson

1 July 1998 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
ASAlberto Sola‐Landa
Alberto Sola‐Landa
JPJavier Pizarro‐Cerdá
Javier Pizarro‐Cerdá
MGMaría-Jesús Grilló
María-Jesús Grilló
EMEdgardo Moreno
Edgardo Moreno
IMIgnacio Moriyón
Ignacio Moriyón
ILIgnacio López‐Goñi
Ignacio López‐Goñi
Two mutants showing increased sensitivity to polycations and surfactants were obtained by transposon mutagenesis of virulent Brucella abortus 2308 Nalr. These mutants showed no obvious in vitro growth defects and produced smooth‐type lipopolysaccharides. However, they hardly multiplied or persisted in mouse spleens, displayed reduced invasiveness in macrophages and HeLa cells, lost the ability to inhibit lysosome fusion and were unable to replicate intracellularly. Subsequent DNA analyses identified a two‐component regulatory system [Brucella virulence related (Bvr)] with a regulatory (BvrR) and sensory (BvrS) protein. Cloning of bvrR in the BvrR‐deficient mutant restored the resistance to polycations and, in part, the invasiveness and the ability to multiply intracellularly. BvrR and BvrS were highly similar (87–89% and 70–80% respectively) to the regulatory and sensory proteins of the chromosomally encoded Rhizobium meliloti ChvI–ExoS and Agrobacterium tumefaciens ChvI–ChvG systems previously shown to be critical for endosymbiosis and pathogenicity in plants. Divergence among the three sensory proteins was located mostly within a periplasmic domain probably involved in stimulus sensing. As B. abortus, R. meliloti and A. tumefaciens are phylogenetically related, these observations suggest that these systems have a common ancestor that has evolved to sense stimuli in plant and animal microbial environments.

18 July 2007 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EBElías Barquero-Calvo
Elías Barquero-Calvo
ECEsteban Chaves-Olarte
Esteban Chaves-Olarte
DWDavid S. Weiss
David S. Weiss
CGCaterina Guzmán-Verri
Caterina Guzmán-Verri
CCCarlos Chacón-Díaz
Carlos Chacón-Díaz
EMEdgardo Moreno
Edgardo Moreno
To unravel the strategy by which Brucella abortus establishes chronic infections, we explored its early interaction with innate immunity. Brucella did not induce proinflammatory responses as demonstrated by the absence of leukocyte recruitment, humoral or cellular blood changes in mice. Brucella hampered neutrophil (PMN) function and PMN depletion did not influence the course of infection. Brucella barely induced proinflammatory cytokines and consumed complement, and was strongly resistant to bactericidal peptides, PMN extracts and serum. Brucella LPS (BrLPS), NH-polysaccharides, cyclic glucans, outer membrane fragments or disrupted bacterial cells displayed low biological activity in mice and cells. The lack of proinflammatory responses was not due to conspicuous inhibitory mechanisms mediated by the invading Brucella or its products. When activated 24 h post-infection macrophages did not kill Brucella, indicating that the replication niche was not fusiogenic with lysosomes. Brucella intracellular replication did not interrupt the cell cycle or caused cytotoxicity in WT, TLR4 and TLR2 knockout cells. TNF-α-induction was TLR4- and TLR2-dependent for live but not for killed B. abortus. However, intracellular replication in TLR4, TLR2 and TLR4/2 knockout cells was not altered and the infection course and anti-Brucella immunity development upon BrLPS injection was unaffected in TLR4 mutant mice. We propose that Brucella has developed a stealth strategy through PAMPs reduction, modification and hiding, ensuring by this manner low stimulatory activity and toxicity for cells. This strategy allows Brucella to reach its replication niche before activation of antimicrobial mechanisms by adaptive immunity. This model is consistent with clinical profiles observed in humans and natural hosts at the onset of infection and could be valid for those intracellular pathogens phylogenetically related to Brucella that also cause long lasting infections.

8 May 2005 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
BABeatriz Arellano-Reynoso
Beatriz Arellano-Reynoso
NLNicolas Lapaque
Nicolas Lapaque
SSSusana Salcedo
Susana Salcedo
GBGabriel Briones
Gabriel Briones
ACAndrés Eduardo Ciocchini
Andrés Eduardo Ciocchini
Jean-Pierre GorvelJean-Pierre Gorvel
Jean-Pierre Gorvel

1 February 2005 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
NLNicolas Lapaque
Nicolas Lapaque
IMIgnacio Moriyón
Ignacio Moriyón
EMEdgardo Moreno
Edgardo Moreno
Jean-Pierre GorvelJean-Pierre Gorvel
Jean-Pierre Gorvel

13 April 2012 in Veterinary Research
Verified
Journal Article
Open access
PDF file
MGMaría-Jesús Grilló
María-Jesús Grilló
JBJose Maria Blasco
Jose Maria Blasco
Jean-Pierre GorvelJean-Pierre Gorvel
Jean-Pierre Gorvel
IMIgnacio Moriyón
Ignacio Moriyón
EMEdgardo Moreno
Edgardo Moreno
Brucellosis is a zoonosis caused by Brucella species. Brucellosis research in natural hosts is often precluded by practical, economical and ethical reasons and mice are widely used. However, mice are not natural Brucella hosts and the course of murine brucellosis depends on bacterial strain virulence, dose and inoculation route as well as breed, genetic background, age, sex and physiological statu of mice. Therefore, meaningful experiments require a definition of these variables. Brucella spleen replication profiles are highly reproducible and course in four phases: i), onset or spleen colonization (first 48 h); ii), acute phase, from the third day to the time when bacteria reach maximal numbers; iii), chronic steady phase, where bacterial numbers plateaus; and iv), chronic declining phase, during which brucellae are eliminated. This pattern displays clear physiopathological signs and is sensitive to small virulence variations, making possible to assess attenuation when fully virulent bacteria are used as controls. Similarly, immunity studies using mice with known defects are possible. Mutations affecting INF-γ, TLR9, Myd88, Tγδ and TNF-β favor Brucella replication; whereas IL-1β, IL-18, TLR4, TLR5, TLR2, NOD1, NOD2, GM-CSF, IL/17r, Rip2, TRIF, NK or Nramp1 deficiencies have no noticeable effects. Splenomegaly development is also useful: it correlates with IFN-γ and IL-12 levels and with Brucella strain virulence. The genetic background is also important: Brucella-resistant mice (C57BL) yield lower splenic bacterial replication and less splenomegaly than susceptible breeds. When inoculum is increased, a saturating dose above which bacterial numbers per organ do not augment, is reached. Unlike many gram-negative bacteria, lethal doses are large (≥ 108bacteria/mouse) and normally higher than the saturating dose. Persistence is a useful virulence/attenuation index and is used in vaccine (Residual Virulence) quality control. Vaccine candidates are also often tested in mice by determining splenic Brucella numbers after challenging with appropriate virulent brucellae doses at precise post-vaccination times. Since most live or killed Brucella vaccines provide some protection in mice, controls immunized with reference vaccines (S19 or Rev1) are critical. Finally, mice have been successfully used to evaluate brucellosis therapies. It is concluded that, when used properly, the mouse is a valuable brucellosis model.